Literature DB >> 18374542

Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia.

Dawn I Velligan1, Pamela M Diamond, Natalie J Maples, James Mintz, Xueying Li, David C Glahn, Alexander L Miller.   

Abstract

We examined the efficacy of 2 treatments using environmental supports (e.g. signs, alarms, pill containers, checklists) to improve functional outcomes in individuals with schizophrenia. 120 participants were randomized into one of 3 treatment groups 1) Cognitive Adaptation Training (CAT; supports customized to individual cognitive impairments and behaviors and maintained on weekly home visits 2) Generic Environmental Supports (GES; a generic set of supports given to patients at a routine clinic visit and replaced on a monthly basis) and 3) treatment as usual (TAU). Functional outcomes, positive symptoms and motivation were assessed at baseline, 3, 6, 9, 18 and 24 months. After 9 months of intensive treatment with CAT, visits were decreased from weekly to monthly to examine whether treatment gains could be maintained. Results of a mixed effects regression model with repeated measures indicated a significant main effect of group (CAT>GES>TAU) with non-significant time and group by time interactions. Post-hoc analyses indicated that while individuals in CAT remained significantly better than those in TAU when treatment frequency was reduced, gains in CAT decreased to the level of those seen in GES. While group differences for positive symptoms were not significant, motivation improved in CAT and GES relative to TAU. The highest intensity treatment produced the best outcomes with respect to functioning. However, some improvements were seen with a relatively inexpensive, clinic-based treatment using a package of generic environmental supports.

Entities:  

Mesh:

Year:  2008        PMID: 18374542      PMCID: PMC2556277          DOI: 10.1016/j.schres.2008.02.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

1.  Two case studies of cognitive adaptation training for outpatients with schizophrenia.

Authors:  D I Velligan; C C Bow-Thomas
Journal:  Psychiatr Serv       Date:  2000-01       Impact factor: 3.084

2.  How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia.

Authors:  John S Brekke; Maanse Hoe; Jeffrey Long; Michael F Green
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

3.  The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.

Authors:  Dawn I Velligan; Pamela M Diamond; Jim Mintz; Natalie Maples; Xueying Li; John Zeber; Larry Ereshefsky; Yui-Wing F Lam; Desiree Castillo; Alexander L Miller
Journal:  Schizophr Bull       Date:  2007-10-10       Impact factor: 9.306

Review 4.  The treatment of negative symptoms: pharmacological and methodological issues.

Authors:  W T Carpenter
Journal:  Br J Psychiatry Suppl       Date:  1996-05

5.  The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia.

Authors:  L D Alphs; A Summerfelt; H Lann; R J Muller
Journal:  Psychopharmacol Bull       Date:  1989

6.  Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report.

Authors:  J A Boczkowski; A Zeichner; N DeSanto
Journal:  J Consult Clin Psychol       Date:  1985-10

7.  A behavioral medicine perspective on adherence to long-term medical regimens.

Authors:  L H Epstein; P A Cluss
Journal:  J Consult Clin Psychol       Date:  1982-12

8.  Neuropsychological function in schizophrenia. Selective impairment in memory and learning.

Authors:  A J Saykin; R C Gur; R E Gur; P D Mozley; L H Mozley; S M Resnick; D B Kester; P Stafiniak
Journal:  Arch Gen Psychiatry       Date:  1991-07

Review 9.  Cognitive deficits in schizophrenia.

Authors:  J M Gold; P D Harvey
Journal:  Psychiatr Clin North Am       Date:  1993-06

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  22 in total

1.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

2.  A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.

Authors:  Dawn I Velligan; David Roberts; Jim Mintz; Natalie Maples; Xueying Li; Elisa Medellin; Matt Brown
Journal:  Schizophr Res       Date:  2015-05-01       Impact factor: 4.939

3.  The Use of Access Groups for Engagement in Community Mental Health Post Hospitalization.

Authors:  David L Roberts; Dawn I Velligan; Megan Fredrick
Journal:  Community Ment Health J       Date:  2017-11-28

4.  Contemporary approaches in mental health rehabilitation.

Authors:  L van der Meer; C Wunderink
Journal:  Epidemiol Psychiatr Sci       Date:  2018-07-25       Impact factor: 6.892

5.  The feasibility of cognitive adaptation training for outpatients with schizophrenia in integrated treatment.

Authors:  Jens Peter Hansen; Birte Østergaard; Merete Nordentoft; Lise Hounsgaard
Journal:  Community Ment Health J       Date:  2012-10-12

6.  Compensatory Interventions for Cognitive Impairments in Psychosis: A Systematic Review and Meta-Analysis.

Authors:  Kelly Allott; Kristi van-der-El; Shayden Bryce; Emma M Parrish; Susan R McGurk; Sarah Hetrick; Christopher R Bowie; Sean Kidd; Matthew Hamilton; Eoin Killackey; Dawn Velligan
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

7.  The cultural adaptability of intermediate measures of functional outcome in schizophrenia.

Authors:  Dawn I Velligan; Maureen Rubin; Megan M Fredrick; Jim Mintz; Keith H Nuechterlein; Nina R Schooler; Judith Jaeger; Nancy M Peters; Raimund Buller; Stephen R Marder; Sanjay Dube
Journal:  Schizophr Bull       Date:  2010-12-06       Impact factor: 9.306

Review 8.  Biomarkers in psychosis: an approach to early identification and individualized treatment.

Authors:  Heline Mirzakhanian; Fiza Singh; Kristin S Cadenhead
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

9.  Factors Associated with Long-Stays in an Italian Psychiatric Intensive Treatment Facility: 1-Year Retrospective Observational Analysis.

Authors:  Rosaria Di Lorenzo; Teresa Olmi; Giulia Rioli; Gian Maria Galeazzi; Paola Ferri
Journal:  Psychiatr Q       Date:  2019-03

10.  Multimodal cognitive therapy: combining treatments that bypass cognitive deficits and deal with reasoning and appraisal biases.

Authors:  Dawn I Velligan; Meredith Draper; Donna Stutes; Natalie Maples; Jim Mintz; Sara Tai; Douglas Turkington
Journal:  Schizophr Bull       Date:  2009-07-20       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.